HIV-1 south african subtype C env proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9598469
APP PUB NO 20140220060A1
SERIAL NO

14141396

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to polynucleotides encoding immunogenic HIV polypeptides. Uses of the polypeptides in applications including immunization, generation of packaging cell lines, and production of HIV polypeptides are also described. Polynucleotides encoding antigenic HIV polypeptides are described, as are uses of these polynucleotides and polypeptide products therefrom, including formulations of immunogenic compositions and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS VACCINES AND DIAGNOSTICS INC4560 HORTON STREET EMERYVILLE CALIFORNIA 94608 UNITED STATES OF AMERICA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barnett, Susan San Francisco, US 33 336
Engelbrecht, Susan Tygerberg, ZA 6 13
Lian, Ying Albany, US 22 62
Scriba, Thomas J Oxford, GB 3 6
Van, Rensberg Estrelita Janse Tygerberg, ZA 1 0
Zur, Megede Jan San Francisco, US 26 62

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00